This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barranco, S. C. Articles by Schellenberg, K. Search for Related Content PubMed Articles by Barranco, S. C. Articles by Schellenberg, K.

Changes in Glutathione Content and Resistance to Anticancer Agents in Human Stomach Cancer Cells Induced by Treatments with Melphalan in Vitro¹

Department of Radiation Oncology and Biophysics [S. C. B., B. W., E. G. B., K. K. M., J. S., N. H. L.] and Biochemistry [K. S.], Eastern Virginia Medical School, Norfolk, Virginia 23507, and Department of Surgery, University of Texas Medical Branch, Galveston, Texas 77550 [C. M. T.]

A clone of a human gastric carcinoma cell line was used to determine whether cells which had survived a treatment with Melphalan would express altered survival responses when treated again with this agent 1 week or more later. Cells were treated for 1 h each week with 2 µg/ml (99% lethal dose). After the first Melphalan treatment, the cells exhibited a 10-fold reduction in sensitivity to Melphalan. This was preceded by a 2-fold increase in intracellular glutathione content. By the end of 10 weekly treatments, the cells were 50 times more resistant than controls (based on changes in survival fractions). They also demonstrated collateral resistance to Actinomycin D, 1-(2-chloroethyl)-3-(4-methylcyclo-hexyl)-1-nitrosourea, galactitol, and X-rays, but showed no change in sensitivity to 5-fluorouracil, bleomycin, and Adriamycin. The resistance to Melphalan was not reversible when treatment was withheld for 4 weeks on two different occasions.

The results suggest that treatment with a high dose of Melphalan either selects an existing population of cells with a high GSH content or induces mutations leading to increased GSH content or both, and this results in the expression of greater Melphalan resistance at the time of other treatments. Furthermore, Melphalan treatment stimulates a 50% increase in GSH content in resistant cells in just 6 h, an 85% increase in 36 h, and a 150% increase in 72 h. L-Buthionine sulfoximine partially reversed the expression of resistance to Melphalan by inducing a 60% reduction in intracellular glutathione content.

¹ This work was supported by NIH Grants CA15397-16, CA32718, and RCDA-1 CA00854.

² To whom requests for reprints should be addressed, at Department of Radiation Oncology and Biophysics, Eastern Virginia Medical Schoolo 2130 Lewis Hall, P. O. Box 1980, Norfolk, VA 23501-1980.

Received 10/24/89. Revised 2/23/90.

This article has been cited by other articles:

				V. Robert, B. Mouille, C. Mayeur, M. Michaud, and F. Blachier Effects of the garlic compound diallyl disulfide on the metabolism, adherence and cell cycle of HT-29 colon carcinoma cells: evidence of sensitive and resistant sub-populations Carcinogenesis, August 1, 2001; 22(8): 1155 - 1161. [Abstract] [Full Text] [PDF]

				P. Poli, A. Buschini, A. Candi, and C. Rossi Bleomycin genotoxicity alteration by glutathione and cytochrome P-450 cellular content in respiratory proficient and deficient strains of Saccharomyces cerevisiae Mutagenesis, March 1, 1999; 14(2): 233 - 238. [Abstract] [Full Text] [PDF]